Janux Therapeutics, Inc. (NASDAQ:JANX) IPO
IPO
Priced at US$17.00 a share on Jun 10, 2021.
- Price
- US$17.00 a share
- Shares offered
- 11,400,000 shares of common stock
- Offering size
- US$193.8 million
- Underwriters' option
- Up to 1,710,000 more shares
- Underwriters
- BofA Securities, Cowen, Evercore ISI, H.C. Wainwright & Co. · In the order on the cover
- Shares delivered
- On or about Jun 15, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Apr 16, 2021 |
| Filed publicly | May 19, 2021 |
| Amended once | Jun 7, 2021 |
| Shares registered with an exchange | Jun 9, 2021 |
| Declared effective by the SEC | Jun 10, 2021 |
| Final prospectus, with the price | Jun 11, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jun 11, 2021 |
| EFFECT · Notice that a registration is effective | Jun 10, 2021 |
| S-1MEF · Registration of more shares for the same offering | Jun 10, 2021 |
| CERT · Exchange's certificate of listing | Jun 10, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 9, 2021 |
| CORRESP · Letter to the SEC | Jun 9, 2021 |
| CORRESP · Letter to the SEC | Jun 9, 2021 |
| CORRESP · Letter to the SEC | Jun 7, 2021 |
| S-1/A · Registration statement, amended | Jun 7, 2021 |
| UPLOAD · Letter from the SEC | May 28, 2021 |
| CORRESP · Letter to the SEC | May 19, 2021 |
| S-1 · Registration statement | May 19, 2021 |
| UPLOAD · Letter from the SEC | May 14, 2021 |
| DRS · Draft registration statement | Apr 16, 2021 |
From the cover of the final prospectus (424B4) filed Jun 11, 2021